We are live on ! Find out more

Phibro Animal Health

PAHC

Market cap $1.53B

37.72 USD

+0.48

1.29%

At close Updated Oct 5, 11:20 AM EDT

1 day

1.29%

5 days

6.37%

1 month

1.1%

3 months

10.52%

6 months

-31.34%

Year to date

1.13%

1 year

-0.19%

5 years

75.28%

10 years

37.97%

About: Phibro Animal Health Corp is a world-wide diversified animal health and mineral nutrition company. It strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. It develop, manufacture and market products for food animals including poultry, beef and dairy cattle, swine, aquaculture and dogs. It has three segments Animal Health, Mineral Nutrition, and Performance Products. Majority of revenue comes from Animal Health segment. Animal health products are anti-bacterials, anticoccidials, nutritional specialty products, and vaccines, and vaccine adjuvants that help improve the animal's health.

Employees: 2,605

Healthcare Drug Manufacturers - Specialty & Generic

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 55.2%

Neutral 41.4%

Negative 3.4%

Zacks Investment Research

Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?

Zacks Investment Research

Best Momentum Stocks to Buy for September 21st

SEI, SDRL and PAHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 21st, 2026.

Best Momentum Stocks to Buy for September 21st

Zacks Investment Research

PAHC vs. HAE: Which Stock Should Value Investors Buy Now?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Haemonetics (HAE). But which of these two stocks presents investors with the better value opportunity right now?

PAHC vs. HAE: Which Stock Should Value Investors Buy Now?

Zacks Investment Research

Phibro Animal Health (PAHC) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Phibro Animal Health (PAHC) is a Top-Ranked Value Stock: Should You Buy?

Zacks Investment Research

4 Stocks With Strong Interest Coverage to Buy as Yields Rise

DiamondRock Hospitality, Vertiv, Mueller Water Products and Phibro Animal Health stand out for strong interest coverage as Treasury yields rise.

4 Stocks With Strong Interest Coverage to Buy as Yields Rise

Zacks Investment Research

Does Phibro (PAHC) Have the Potential to Rally 25.77% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 25.8% in Phibro (PAHC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Does Phibro (PAHC) Have the Potential to Rally 25.77% as Wall Street Analysts Expect?

Zacks Investment Research

Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term

Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference. President & Chief Executive Officer, Daniel Bendheim; Chief Operating Officer, Larry Miller; and Chief Financial Officer, Glenn David will address financial analysts and investors on Tuesday, September 15, 2026, at 1:05 PM ET at New York Marriott Marquis in New York. The live audio presentation will be available on the.

Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference

Zacks Investment Research

PAHC or LMAT: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and LeMaitre Vascular (LMAT). But which of these two stocks is more attractive to value investors?

PAHC or LMAT: Which Is the Better Value Stock Right Now?

Zacks Investment Research

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

See News Rankings

Price charts implemented using Lightweight Charts™